Susquehanna International Group
DRMA icon

Susquehanna International Group’s Dermata Therapeutics DRMA Stock Holding History

Susquehanna International Group’s Portfolio DRMA Stock Details DRMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Buy
+15,989
New +$20.1K ﹤0.01% 13038
2023
Q3 		– Sell
-84
Closed -$20.9K – 12193
2023
Q2 		$20.9K Buy
+84
New +$22.9K ﹤0.01% 11628
2022
Q3 		– Sell
-5
Closed -$7K – 13352
2022
Q2 		$7K Buy
+5
New +$10.3K ﹤0.01% 12566

Other funds holding DRMA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.8B AUM 19.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Susquehanna International Group's DRMA Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Dermata Therapeutics (DRMA) in Q2 2026: 15,989 shares worth $20.6K. The stake represents ﹤0.01% of the portfolio and ranks #13038 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in DRMA as recently as Q2 2023.

Susquehanna International Group first reported a position in DRMA in Q2 2022 and has held it in 3 quarters since. The position peaked at $20.9K in Q2 2023. 13 funds tracked by Wall St. Rank hold DRMA as of Q2 2026.

  • Susquehanna International Group held 15,989 shares of Dermata Therapeutics worth $20.6K as of Q2 2026.
  • Dermata Therapeutics was a new Susquehanna International Group position in Q2 2026.
  • Dermata Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13038 holding.
  • Susquehanna International Group first reported a position in Dermata Therapeutics in Q2 2022 and has held it in 3 quarters since.
  • Susquehanna International Group's Dermata Therapeutics position peaked at $20.9K in Q2 2023.
  • 13 funds tracked by Wall St. Rank held Dermata Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.